Satellos Bioscience MSLE
NASDAQ MSLE
$6.75 -0.45 (-6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Satellos Bioscience (MSLE) Other Operating Expenses (2024 - 2025)

Updated

Satellos Bioscience's Other Operating Expenses was -$26.46 million in the quarter ended Dec 31, 2025, compared with -$20.4 million a year earlier.

Analysis

Satellos Bioscience (MSLE) Other Operating Expenses (2024 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Other Operating Expenses at Satellos Bioscience came in at -$52.92 million.

  • In earlier years, Other Operating Expenses was -$39.81 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Satellos Bioscience 109.60 Mn -98.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 26.46 Mn
Dec 31, 2024 20.40 Mn
API Access

Satellos Bioscience Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=MSLE&period=max&api_key=YOUR_API_KEY